Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P De Backer

Showing results (21-30 of 60) with videos related to

Pageof 6
Sort By:
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 1, 1995
Dopamine agonists used in the treatment of Parkinson's disease and their selectivity for the D1, D2, and D3 dopamine receptors in human striatumJ De Keyser, J P De Backer, N Wilczak, et al.
Brain Research|September 4, 1989
Coupling of D1 dopamine receptors to the guanine nucleotide binding protein Gs is deficient in Huntington's diseaseJ De Keyser, J P De Backer, G Ebinger, et al.
European Journal of Pharmacology|July 8, 1999
Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist bindingF L Fierens, P M Vanderheyden, J P De Backer, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 24, 2004
AT1 receptor antagonistsI Verheijen, P M L Vanderheyden, J P De Backer, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2012
Medicinal plants in Suriname: screening of plant extracts for receptorbinding activityJ A Hasrat, J P De Backer, G Vauquelin, et al.
Journal of the American Society of Nephrology : JASN|January 19, 1999
The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cellsG Vauquelin, F L Fierens, J P De Backer, et al.
Neurochemistry International|July 1, 1997
The novel alpha 2-adrenoceptor agonist [3H]mivazerol binds to non-adrenergic binding sites in human striatum membranes that are distinct from imidazoline receptorsA Flamez, M Gillard, J P De Backer, et al.
Journal of Receptor and Signal Transduction Research|January 8, 1999
[3H]-BIBP3226 and [3H]-NPY binding to intact SK-N-MC cells and CHO cells expressing the human Y1 receptorP M Vanderheyden, I Van Liefde, J P de Backer, et al.
Neurochemistry International|January 1, 1997
Pharmacological characterization of I1 and I2 imidazoline receptors in human striatumA Flamez, J P De Backer, E Czerwiec, et al.
European Journal of Pharmacology|July 23, 1997
Non-competitive binding of the nonpeptide antagonist BIBP3226 to rat forebrain neuropeptide Y1 receptorsP M Vanderheyden, I Van Liefde, J P De Backer, et al.
Pageof 6

Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 1, 1995
Dopamine agonists used in the treatment of Parkinson's disease and their selectivity for the D1, D2, and D3 dopamine receptors in human striatumJ De Keyser, J P De Backer, N Wilczak, et al.
Brain Research|September 4, 1989
Coupling of D1 dopamine receptors to the guanine nucleotide binding protein Gs is deficient in Huntington's diseaseJ De Keyser, J P De Backer, G Ebinger, et al.
European Journal of Pharmacology|July 8, 1999
Insurmountable angiotensin AT1 receptor antagonists: the role of tight antagonist bindingF L Fierens, P M Vanderheyden, J P De Backer, et al.
Current Medicinal Chemistry. Cardiovascular and Hematological Agents|August 24, 2004
AT1 receptor antagonistsI Verheijen, P M L Vanderheyden, J P De Backer, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|December 1, 2012
Medicinal plants in Suriname: screening of plant extracts for receptorbinding activityJ A Hasrat, J P De Backer, G Vauquelin, et al.
Journal of the American Society of Nephrology : JASN|January 19, 1999
The effects of candesartan on human AT1 receptor-expressing Chinese hamster ovary cellsG Vauquelin, F L Fierens, J P De Backer, et al.
Neurochemistry International|July 1, 1997
The novel alpha 2-adrenoceptor agonist [3H]mivazerol binds to non-adrenergic binding sites in human striatum membranes that are distinct from imidazoline receptorsA Flamez, M Gillard, J P De Backer, et al.
Journal of Receptor and Signal Transduction Research|January 8, 1999
[3H]-BIBP3226 and [3H]-NPY binding to intact SK-N-MC cells and CHO cells expressing the human Y1 receptorP M Vanderheyden, I Van Liefde, J P de Backer, et al.
Neurochemistry International|January 1, 1997
Pharmacological characterization of I1 and I2 imidazoline receptors in human striatumA Flamez, J P De Backer, E Czerwiec, et al.
European Journal of Pharmacology|July 23, 1997
Non-competitive binding of the nonpeptide antagonist BIBP3226 to rat forebrain neuropeptide Y1 receptorsP M Vanderheyden, I Van Liefde, J P De Backer, et al.
Pageof 6